Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Indian J Pharm Sci ; 74(1): 75-9, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23204627

RESUMO

The hazards of prescribing many drugs, including side-effects, drug-drug interactions and difficulties of compliance have long been recognized as particular problems when prescribing. This study estimates the rate and factors associated with potential drug-drug interactions in prescriptions from wards of An Iranian General Hospital. Data were retrieved from the pharmacy of a general hospital (200 beds) during one year period 2010. Potential drug-drug interaction were identified using a computerized drug-drug interaction database system (Prescription Analyzer 2000, Sara Rayane Co., Iran). Patients of both genders and 15 years-old or more were included in this study. Prescriptions with two or more drugs prescribed were selected during one year period 2010. Gender number of drugs and therapeutic drug classes on prescriptions were explored as associated factors to drug-drug interaction. The overall prevalence of potential drug-drug interaction was 20.3%. The risks of severe potential drug interactions were relatively high and the rate of potential drug-drug interaction was significantly higher in women (60.6%) and the patients aged over 60 years old (57.1%). The frequency of the potentially severe drug-drug interaction was 10.8% with digoxin-furosemide as the most common interacting pair (5.91%). A positive correlation was found between drug-drug interaction, patient's age, number of drugs and drugs acting on cardiovascular system. So cardiology women inpatients, age more then 60 years old, and patients prescribed digoxin and angiotensin-converting enzyme inhibitors should be closely monitored for adverse outcomes from drug-drug interaction.

2.
Cardiovasc J Afr ; 22(6): 319-23, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22159320

RESUMO

OBJECTIVES: Previous studies have suggested that failure of the synthesis of nitric oxide is involved in the pathophysiology of myocardial ischaemia-reperfusion injury. In this study, we investigated the effect of mebudipine, a new dihydropyridine calcium channel blocker, on cardiac function and activity of the myocardial nitric oxide system in ischaemia-reperfusion injury in isolated rat hearts. METHODS: Forty male Wistar rats (250-300 g) were divided into four groups (n = 10): sham, control, vehicle and drug groups. The animals were anesthetised with sodium pentobarbital (6 mg/kg intraperitoneal). The hearts were quickly removed, mounted on a Longendorff apparatus and perfused with Krebs-Henseleit solution under constant pressure at 37°C. After 20 min stabilisation period, the ischaemic groups received 30 min global ischaemia and 120 min reperfusion. For the drug and vehicle groups, before ischaemia the hearts were perfused with mebudipine (10(-3) µM) or ethanol-enriched solution (0.01%) for 25 min, respectively. Myocardial function, and creatine kinase, lactate dehydrogenase and total nitric oxide metabolite (nitrite and nitrate) levels were analysed. RESULTS: Cardiac functions had recovered significantly in the mebudipine group (p < 0.01). Furthermore, mebudipine remarkably reduced the levels of lactate dehydrogenase and creatine kinase in the coronary effluent and increased myocardial nitric oxide metabolite levels compared with the control group. CONCLUSION: Our results indicate that mebudipine reduced the intensity of myocardial ischaemia-reperfusion injury, and that activation of the myocardial nitric oxide system played an important role in this regard.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Coração/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Nifedipino/análogos & derivados , Óxido Nítrico/metabolismo , Traumatismo por Reperfusão/prevenção & controle , Animais , Circulação Coronária/efeitos dos fármacos , Creatina Quinase/efeitos dos fármacos , L-Lactato Desidrogenase/efeitos dos fármacos , Masculino , Nifedipino/farmacologia , Nitratos/metabolismo , Nitritos/metabolismo , Ratos , Ratos Wistar
3.
Iran Red Crescent Med J ; 13(12): 891-4, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22737435

RESUMO

BACKGROUND: Chronic supportive otitis media (CSOM) is one of the commonest illnesses in ENT practice. This study was conducted to find out the various aerobic microorganisms associated with CSOM and their current antimicrobial susceptibility patterns to commonly used antimicrobials. METHODS: samples were collected from 117 clinically diagnosed cases of CSOM and processed according to standard protocols. RESULTS: Out of 117 CSOM cases, 105 (86%) showed positive bacterial culture. The Staphylococcus aureus was the commonest aerobic isolate in CSOM. The sensitivity of Staphylococci spp. to commonly used antimicrobials varied from 27.2% for cefixime to 95.5% for gentamicin and coagulase positive. Pseudomonas isolates showed complete (100%) resistance to amoxicillin/clavulanate (co-amoxiclave), cloxacillin and cefixime, and high sensitivity to ciprofloxacin (95%) and cephalexin (90%). CONCLUSION: An appropriate knowledge of antibacterial susceptibility of microorganisms would contribute to a rational antibiotic use and the success of treatment for chronic supportive otitis media.

4.
Eur J Anaesthesiol ; 25(2): 129-34, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17697423

RESUMO

BACKGROUND AND OBJECTIVE: Visceral pain is one of the most common forms of pain and for which new drugs would be welcome. The aim of this study was to investigate whether gabapentin inhibits induced abdominal contractions in mice and to examine the effect of its co-administration with morphine. METHODS: A total of 96 mice received acetic acid intraperitoneally after administration of saline or gabapentin (1, 5, 10, 50 and 100 mg kg(-1)) or morphine (0.25, 0.5, 1, 3 and 5 mg kg(-1)) or a combination of morphine and gabapentin. Other groups also received naloxone. The number of writhes were counted. RESULTS: Both gabapentin and morphine reduced writhing in a dose-dependent manner. The number of writhes was decreased significantly by gabapentin (50 and 100 mg kg(-1)) and morphine (0.5, 1, 3 and 5 mg kg(-1)) (P < 0.001). Also, the lowest dose of morphine 0.25 mg kg(-1) when combined with low doses of gabapentin significantly decreased the number of writhes (P < 0.005). The combination of a low effective dose of gabapentin (50 mg kg(-1)) with a low dose of morphine decreased the writhing by 94% as compared to the controls. The antinociceptive effect of combined administration was not reversed by naloxone. CONCLUSION: These data demonstrated the comparable efficacy of gabapentin with morphine in visceral pain. Also, the results showed that the combination of doses of gabapentin and morphine, which were ineffective alone, produced a significant analgesic effect in the writhing model of pain. This may be clinically important in the management of visceral pain.


Assuntos
Aminas/farmacologia , Analgésicos Opioides/farmacologia , Analgésicos/farmacologia , Ácidos Cicloexanocarboxílicos/farmacologia , Morfina/farmacologia , Dor/tratamento farmacológico , Ácido gama-Aminobutírico/farmacologia , Ácido Acético/administração & dosagem , Análise de Variância , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Gabapentina , Masculino , Camundongos , Naloxona/administração & dosagem , Antagonistas de Entorpecentes/administração & dosagem , Dor/induzido quimicamente , Medição da Dor/efeitos dos fármacos , Cloreto de Sódio/administração & dosagem
5.
Farmaco ; 57(3): 195-9, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11989797

RESUMO

Various diester analogues of nifedipine, in which the orthonitrophenyl group at position 4 is replaced by 1-methyl-2-methylthio-5-imidazolyl substituent, were synthesized and evaluated as calcium channel antagonists on guinea-pig ileal smooth muscle. Nifedipine was used as standard. Comparison of the activities of symmetrical esters (3a-e) indicate that increasing the length of alkyl chain in C3 and C5 ester substituents increases the antagonist activity and the n-propyl ester being preferred (IC50= 2.66 x 10(-9) M). In asymmetrical series (6a-g), compound 6g having ethyl and n-butyl ester at C3 and C5 positions of basic dihydropyridine structure was found to be the most active (IC50= 1.32 x 10(-9) M).


Assuntos
Bloqueadores dos Canais de Cálcio/síntese química , Bloqueadores dos Canais de Cálcio/farmacologia , Imidazóis/síntese química , Imidazóis/farmacologia , Nifedipino/análogos & derivados , Animais , Di-Hidropiridinas/síntese química , Di-Hidropiridinas/farmacologia , Relação Dose-Resposta a Droga , Cobaias , Íleo/efeitos dos fármacos , Íleo/metabolismo , Íleo/fisiologia , Técnicas In Vitro , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Masculino , Espectrometria de Massas , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiologia , Nifedipino/farmacologia , Cloreto de Potássio/química , Cloreto de Potássio/metabolismo , Espectrofotometria Infravermelho , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...